The starting point of this investigation is a US-headquartered group of companies reporting over €1 billion in worldwide sales of Covid-19 and other rapid diagnostics tests out of Ireland, with nearly half of this amount emerging as profit in another country where it is subject to a much lower tax rate than here. Sounds familiar? For over 30 years, US-headquartered multinationals used the infamous double Irish corporate structure to book international sales of products and services in Ireland. The portion of American technology and brands underpinning those revenues was placed in separate companies incorporated in Ireland but domiciled offshore in…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €50.

Subscribe

Cancel at any time.

Are you already a member? .